|
|
International Journal of Health Policy and Management، جلد ۷، شماره ۳، صفحات ۲۰۱-۲۰۶
|
|
|
| عنوان فارسی |
|
|
| چکیده فارسی مقاله |
|
|
| کلیدواژه‌های فارسی مقاله |
|
|
| عنوان انگلیسی |
BRIC Health Systems and Big Pharma: A Challenge for Health Policy and Management |
|
| چکیده انگلیسی مقاله |
BRIC nations – Brazil, Russia, India, and China – represent 40% of the world's population, including a growing aging population and middle class with an increasing prevalence of chronic disease. Their healthcare systems increasingly rely on prescription drugs, but they differ from most other healthcare systems because healthcare expenditures in BRIC nations have exhibited the highest revenue growth rates for pharmaceutical multinational corporations (MNCs), Big Pharma. The response of BRIC nations to Big Pharma presents contrasting cases of how governments manage the tensions posed by rising public expectations and limited resources to satisfy them. Understanding these tensions represents an emerging area of research and an important challenge for all those who work in the field of health policy and management (HPAM). |
|
| کلیدواژه‌های انگلیسی مقاله |
|
|
| نویسندگان مقاله |
ویکتور g rodwin | victor g
robert f. wagner graduate school of public service, new york university, new york city, ny, usa
guilhem fabre |
université paul valéry montpellier 3, iriec ea 740, montpellier, france
رافایل f ایوب | rafael f
wagner school of public service, newyork university, new york city, ny, usa
|
|
| نشانی اینترنتی |
http://www.ijhpm.com/article_3449_9bc5018d41727832f6c4aa408a2ecf02.pdf |
| فایل مقاله |
اشکال در دسترسی به فایل - ./files/site1/rds_journals/291/article-291-572332.pdf |
| کد مقاله (doi) |
|
| زبان مقاله منتشر شده |
en |
| موضوعات مقاله منتشر شده |
|
| نوع مقاله منتشر شده |
|
|
|
|
برگشت به:
صفحه اول پایگاه |
نسخه مرتبط |
نشریه مرتبط |
فهرست نشریات
|